Favipiravir tablets and preparation method thereof
The invention relates to favipiravir tablets. The tablets comprise favipiravir, silicified microcrystalline cellulose and adhesive; the silicified microcrystalline cellulose is lower in price, proper in size and high in medicine compliance when being compared with low-substituted hydroxypropyl cellu...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZHANG WEILING LIU YONGJIN LIU CUIYAN ZHANG YUANYUAN ZHANG HONGFEN BU LICHAO BAI JING |
| description | The invention relates to favipiravir tablets. The tablets comprise favipiravir, silicified microcrystalline cellulose and adhesive; the silicified microcrystalline cellulose is lower in price, proper in size and high in medicine compliance when being compared with low-substituted hydroxypropyl cellulose; the defective rate is lower and the dissolution rate is higher. The invention further relates to a preparation method of the tablets. The preparation method is simple in preparation process and suitable for industrialized large-scale production.
本发明涉及种法匹拉韦片剂，该片剂含有法匹拉韦、硅化微晶纤维素和粘合剂，采用硅化微晶纤维素相对于低取代羟丙基纤维素，价格更加低廉、大小合适、药物顺应性良好，并且次品率更低和溶出更好。本发明还涉及所述片剂的制备方法，该制备方法制备工艺简单，适合工业化大生产。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN106667926A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN106667926A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN106667926A3</originalsourceid><addsrcrecordid>eNrjZDBySyzLLMgsApJFCiWJSTmpJcUKiXkpCgVFqQWJRYklmfl5CrmpJRn5KQolGalFqflpPAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3tnP0MDMzMzc0sjM0ZgYNQD5DiyH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Favipiravir tablets and preparation method thereof</title><source>esp@cenet</source><creator>ZHANG WEILING ; LIU YONGJIN ; LIU CUIYAN ; ZHANG YUANYUAN ; ZHANG HONGFEN ; BU LICHAO ; BAI JING</creator><creatorcontrib>ZHANG WEILING ; LIU YONGJIN ; LIU CUIYAN ; ZHANG YUANYUAN ; ZHANG HONGFEN ; BU LICHAO ; BAI JING</creatorcontrib><description>The invention relates to favipiravir tablets. The tablets comprise favipiravir, silicified microcrystalline cellulose and adhesive; the silicified microcrystalline cellulose is lower in price, proper in size and high in medicine compliance when being compared with low-substituted hydroxypropyl cellulose; the defective rate is lower and the dissolution rate is higher. The invention further relates to a preparation method of the tablets. The preparation method is simple in preparation process and suitable for industrialized large-scale production.
本发明涉及种法匹拉韦片剂，该片剂含有法匹拉韦、硅化微晶纤维素和粘合剂，采用硅化微晶纤维素相对于低取代羟丙基纤维素，价格更加低廉、大小合适、药物顺应性良好，并且次品率更低和溶出更好。本发明还涉及所述片剂的制备方法，该制备方法制备工艺简单，适合工业化大生产。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170517&DB=EPODOC&CC=CN&NR=106667926A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170517&DB=EPODOC&CC=CN&NR=106667926A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHANG WEILING</creatorcontrib><creatorcontrib>LIU YONGJIN</creatorcontrib><creatorcontrib>LIU CUIYAN</creatorcontrib><creatorcontrib>ZHANG YUANYUAN</creatorcontrib><creatorcontrib>ZHANG HONGFEN</creatorcontrib><creatorcontrib>BU LICHAO</creatorcontrib><creatorcontrib>BAI JING</creatorcontrib><title>Favipiravir tablets and preparation method thereof</title><description>The invention relates to favipiravir tablets. The tablets comprise favipiravir, silicified microcrystalline cellulose and adhesive; the silicified microcrystalline cellulose is lower in price, proper in size and high in medicine compliance when being compared with low-substituted hydroxypropyl cellulose; the defective rate is lower and the dissolution rate is higher. The invention further relates to a preparation method of the tablets. The preparation method is simple in preparation process and suitable for industrialized large-scale production.
本发明涉及种法匹拉韦片剂，该片剂含有法匹拉韦、硅化微晶纤维素和粘合剂，采用硅化微晶纤维素相对于低取代羟丙基纤维素，价格更加低廉、大小合适、药物顺应性良好，并且次品率更低和溶出更好。本发明还涉及所述片剂的制备方法，该制备方法制备工艺简单，适合工业化大生产。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBySyzLLMgsApJFCiWJSTmpJcUKiXkpCgVFqQWJRYklmfl5CrmpJRn5KQolGalFqflpPAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3tnP0MDMzMzc0sjM0ZgYNQD5DiyH</recordid><startdate>20170517</startdate><enddate>20170517</enddate><creator>ZHANG WEILING</creator><creator>LIU YONGJIN</creator><creator>LIU CUIYAN</creator><creator>ZHANG YUANYUAN</creator><creator>ZHANG HONGFEN</creator><creator>BU LICHAO</creator><creator>BAI JING</creator><scope>EVB</scope></search><sort><creationdate>20170517</creationdate><title>Favipiravir tablets and preparation method thereof</title><author>ZHANG WEILING ; LIU YONGJIN ; LIU CUIYAN ; ZHANG YUANYUAN ; ZHANG HONGFEN ; BU LICHAO ; BAI JING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN106667926A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHANG WEILING</creatorcontrib><creatorcontrib>LIU YONGJIN</creatorcontrib><creatorcontrib>LIU CUIYAN</creatorcontrib><creatorcontrib>ZHANG YUANYUAN</creatorcontrib><creatorcontrib>ZHANG HONGFEN</creatorcontrib><creatorcontrib>BU LICHAO</creatorcontrib><creatorcontrib>BAI JING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHANG WEILING</au><au>LIU YONGJIN</au><au>LIU CUIYAN</au><au>ZHANG YUANYUAN</au><au>ZHANG HONGFEN</au><au>BU LICHAO</au><au>BAI JING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Favipiravir tablets and preparation method thereof</title><date>2017-05-17</date><risdate>2017</risdate><abstract>The invention relates to favipiravir tablets. The tablets comprise favipiravir, silicified microcrystalline cellulose and adhesive; the silicified microcrystalline cellulose is lower in price, proper in size and high in medicine compliance when being compared with low-substituted hydroxypropyl cellulose; the defective rate is lower and the dissolution rate is higher. The invention further relates to a preparation method of the tablets. The preparation method is simple in preparation process and suitable for industrialized large-scale production.
本发明涉及种法匹拉韦片剂，该片剂含有法匹拉韦、硅化微晶纤维素和粘合剂，采用硅化微晶纤维素相对于低取代羟丙基纤维素，价格更加低廉、大小合适、药物顺应性良好，并且次品率更低和溶出更好。本发明还涉及所述片剂的制备方法，该制备方法制备工艺简单，适合工业化大生产。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN106667926A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Favipiravir tablets and preparation method thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T10%3A19%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHANG%20WEILING&rft.date=2017-05-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN106667926A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |